For example, previous work showed that exogenous human IL-4 (5 nM) enhanced the growth of COLO-357 [50], and further studies confirmed that IL-4 exerted dose-dependent increases in the growth of four other cultured pancreatic cancer cell lines [54]. This evidence concerns the gene IL4 and familial pancreatic carcinoma.